Volume 134, Issue 4 pp. 954-960
Epidemiology

Endometrial thickness and risk of breast and endometrial carcinomas in the prostate, lung, colorectal and ovarian cancer screening trial

Ashley S. Felix

Corresponding Author

Ashley S. Felix

Cancer Prevention Fellowship Program, Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Rockville, MD

Hormonal and Reproductive Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD

Correspondence to: Ashley S. Felix, Cancer Prevention Fellowship Program, Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Rockville, MD, USA, E-mail: [email protected]Search for more papers by this author
Joel L. Weissfeld

Joel L. Weissfeld

Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA

Search for more papers by this author
Ruth M. Pfeiffer

Ruth M. Pfeiffer

Biostatistics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD

Search for more papers by this author
Francesmary Modugno

Francesmary Modugno

Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA

Women's Cancer Research Program, Magee-Women's Research Institute and University of Pittsburgh Cancer Institute, Pittsburgh, PA

Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, PA

Search for more papers by this author
Amanda Black

Amanda Black

Epidemiology and Biostatistics Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD

Search for more papers by this author
Lyndon M. Hill

Lyndon M. Hill

Department of Obstetrics, Gynecology, and Reproductive Sciences, Magee-Women's Hospital, University of Pittsburgh, Pittsburgh, PA

Search for more papers by this author
Jerry Martin

Jerry Martin

Department of Obstetrics, Gynecology, and Reproductive Sciences, Magee-Women's Hospital, University of Pittsburgh, Pittsburgh, PA

Search for more papers by this author
Anita S. Sit

Anita S. Sit

Department of Obstetrics and Gynecology, Santa Clara Valley Medical Center, San Jose, CA

Search for more papers by this author
Mark E. Sherman

Mark E. Sherman

Hormonal and Reproductive Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD

Search for more papers by this author
Louise A. Brinton

Louise A. Brinton

Hormonal and Reproductive Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD

Search for more papers by this author
First published: 31 July 2013
Citations: 13

This article is a U.S. Government work, and, as such, is in the public domain in the United States of America.

Abstract

Postmenopausal women with higher circulating estrogen levels are at increased risk of developing breast and endometrial carcinomas. In the endometrium, excess estrogen relative to progesterone produces a net proliferative stimulus, which may result in endometrial thickening. Therefore, the hypothesis that endometrial thickness is a biological marker of excess estrogen stimulation that is associated with risk of breast and endometrial carcinomas was tested. Endometrial thickness was measured in 1,272 postmenopausal women, aged 55–74 years, who underwent transvaginal ultrasound (TVU) screening as part of the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. Serial endometrial thickness measurements were available for a subset of women at 1 year (n = 1,018), 2 years (n = 869) and 3 years (n = 641) after baseline. The associations between endometrial thickness and breast (n = 91) and endometrial (n = 14) carcinoma were evaluated by estimating relative risks (RRs) and 95% confidence intervals (CIs) using Cox proportional hazards regression with age as the time metric. Models incorporating baseline endometrial thickness and as a time-varying covariate using all measurements were examined. Median follow-up among study participants was 12.5 years (range: 0.3–13.8 years). Compared to baseline endometrial thickness of 1.0–2.99 mm, women with baseline endometrial thickness greater than or equal to 5.0 mm had an increased risk of breast (RR = 2.00, 95% CI = 1.15–3.48) and endometrial (RR = 5.02, 95% CI = 0.96–26.36) carcinomas in models adjusted for menopausal hormone use and BMI. These data suggest that increased endometrial thickness as assessed by TVU was associated with increased risk of breast and endometrial carcinomas.

Abstract

What's new?

Endometrial thickness is related to obesity and menopausal hormone use, factors associated with a higher incidence of breast and endometrial carcinomas. Given these associations, the authors of this study investigated whether endometrial thickness was independently associated with incident breast or endometrial carcinoma risk. In a cohort of 1,272 women, an endometrial thickness greater than five millimeters was associated with a two-fold increase in risk for breast carcinoma and a five-fold increase in risk for endometrial carcinoma.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.